Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Amortizatization of Intangibles (2024 - 2025)

Kairos Pharma's Amortizatization of Intangibles history spans 2 years, with the latest figure at $40000.0 for Q2 2025.

  • For Q2 2025, Amortizatization of Intangibles rose 110.53% year-over-year to $40000.0; the TTM value through Jun 2025 reached $195000.0, changed N/A, while the annual FY2025 figure was $160000.0, 3.9% up from the prior year.
  • Amortizatization of Intangibles reached $40000.0 in Q2 2025 per KAPA's latest filing, roughly flat from $40000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $115000.0 in Q3 2024 to a low of $19000.0 in Q2 2024.